HC Wainwright initiated coverage on MoonLake Immunotherapeutics (NASDAQ:MLTX) with a Buy rating and a price target of $28, citing a potentially best-in-class…
Raymond James analyst Brian Gesuale initiates coverage on Palantir Technologies (NYSE:PLTR) with a Strong Buy rating and announces Price Target of $20.